Finding better ways to develop new drugs using protein kinases.
Official title: Improving Drug Development Through Studies of Protein Kinase Inhibitors
Funded at State University of New York at Buffalo · NIH-11137791 · Data updated 2026-11-12
This study is looking for better ways to develop new medicines by focusing on proteins called kinases, using special compounds to help find promising drug targets faster, so that new treatments can reach patients more quickly.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project start | August 1, 2024 |
| Project end | May 31, 2029 |
| Funding year | 2025 |
| Award (this year) | $401,217 |
| NIH project number | 5R35GM155353-02 |
| Project ID | NIH-11137791 on NIH RePORTER |
Who could benefit from this research
✓Could help
Patients with conditions that are currently difficult to treat or for which new therapies are urgently needed would be ideal candidates to benefit from this research.
✕Less likely to help
Patients with well-established treatment options or those not affected by conditions targeted by this research may not receive benefit.
What this research studies
This research focuses on improving the drug development process, which is often lengthy and uncertain. By studying protein kinases, the research aims to identify new methods that can streamline the development of therapies. The team will utilize innovative compounds called ATP-allosteric bivalent inhibitors (AABIs) to target specific states of kinases, which could lead to faster identification of promising drug targets. The goal is to enhance the efficiency of drug discovery and ultimately bring new treatments to patients more quickly.
Why it matters
Potential benefit: If successful, this research could lead to faster and more reliable development of new medications for various diseases.
How similar studies have gone: Other research has shown promise in improving drug development processes using similar innovative approaches, suggesting potential for success in this area.
Where this research is happening
-
State University of New York at Buffalo
Amherst, United States Active
Researchers
- Principal investigator: Heppner, David E. — State University of New York at Buffalo
- Study coordinator: Heppner, David E.
Related research
Other NIH-funded projects on the same topics.
-
Improving population health by studying reproductive health and development.
This study is looking at how different factors, like the environment and genetics, affect the health of pregnant women and people of reproductive age, with the goal of improving pregnancy outcomes and the health of children as they grow up.
-
How noise and hearing loss affect the first step of hearing in the brain
This NIH grant studies how noise and conductive hearing loss change the intimate connections between auditory nerves and brain cells, which could influence how we hear in noisy environments.
-
Programmable hydrogels to protect transplanted human OPCs in demyelinating disease
Aims to improve survival and integration of transplanted human oligodendrocyte precursor cells by using specially designed hydrogels to reduce cell death during delivery in demyelinating diseases like multiple sclerosis.
-
How a mouth bacterium might fuel gum disease and heart risk
A small study will look at how a bacterium in the mouth that makes a reactive chemical (methylglyoxal) could drive gum inflammation and changes in the mouth’s bacteria, possibly linking to heart disease.
-
New dual-acting treatments against tough Klebsiella pneumoniae infections
A new funding opportunity aims to develop therapies that both fight and disarm the dangerous Klebsiella pneumoniae bacteria, especially strains that resist many drugs, to help patients with serious infections.
-
Muscle health and aging in postmenopausal women
This NIH grant supports a study in older, postmenopausal women to understand how insulin and blood sugar relate to muscle loss over time and whether this differs by race/ethnicity.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.